Related Experiment Video
Updated: Jan 9, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Enhanced Nutritional Support May Ameliorate Rivaroxaban-Related Rapid Renal Function Decline: New Insights from a
Cheng Meng1, Linjie Li2, Ying Han2
1Department of Nephrology, Kidney Disease Medical Center, General Hospital, Tianjin Medical University, National Key Clinical Specialty, Tianjin Key Medical Discipline, Tianjin, People's Republic of China.
Aim:
Aim to compare the effects of rivaroxaban and warfarin on rapid renal function decline.
Methods:
8842 patients from the Tianjin Health and Medical Data Platform, with a 2.3 years median follow-up (interquartile range,1.5-3.4), were assigned to either the warfarin group (n = 3913) or rivaroxaban group (n = 4929). Logistic models, inverse probability of treatment weighting(IPTW), and propensity score-matched (PSM) analyses were employed to compare the risk of rapid renal function decline associated with rivaroxaban versus warfarin. The multivariable fractional polynomial interaction(MFPI) was used to investigate interactions between continuous variables and the adverse outcome. Restricted cubic splines(RCS) were applied to assess the relationship between the prognostic nutritional index (PNI) score and the adverse outcome.
Results:
Rivaroxaban was associated with an increased risk of rapid renal function decline compared with warfarin in both the univariate (odds ratio [OR], 1.24; 95% confidence interval [CI], 1.14-1.36; P < 0.001) and multivariate (OR, 1.17; 95% CI, 1.07-1.29; P = 0.001) logistic models. Similar trends were observed in the IPTW (OR, 1.16; 95% CI, 1.09-1.33; P < 0.001), PSM model (OR, 1.21; 95% CI, 1.09-1.33; P < 0.001), and all subgroup analyses. In the MFPI analysis, the adverse outcome was significantly alleviated with an increasing PNI score (threshold at PNI score of 50, P = 0.039). A linear negative relationship (P for nonlinearity = 0.221) between the PNI score and rapid renal function decline was observed in patients receiving rivaroxaban.
Conclusion:
Rivaroxaban was associated with a higher risk of rapid renal function decline than warfarin. Enhanced nutritional support may help mitigate this adverse outcome.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury VI: Nursing Management

